UnannouncedVCRaise

Unannounced · 443 daysFiled 1 July 2025

Arialys Therapeutics, Inc. raised $14.8M

Arialys Therapeutics, Inc., a biotech company based in La Jolla, CA, raised $14.8M in a new equity round, according to a filing dated 1 July 2025.

No public announcement found as of 16 September 2026, 443 days after the filing.

Filed
1 July 2025
Round
Equity round
Amount sold
$14.8M
Offering size
$24.8M
Investors so far
7
Based in
La Jolla, CA
Website
arialysrx.com

Investors on the board

Firms come from the venture funds whose filings name a director of this company.

Who is on the board

1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.

Sign in with Google

How it compares

Larger than 65% of the 1,404 tracked raises with an amount filed in 2025, and than 55% of the 112 in biotech.

Arialys Therapeutics, Inc. in public filings

FiledFilingSoldRaise
1 Jul 2025New filing$14.8MThis raise
2 Dec 2022New filing$14.3MAnother raise

Everything on Arialys Therapeutics, Inc.

More with MPM BioVentures on the board

  1. Crossbow Therapeutics, Inc.$30.2MUnannounced · 352 days30 Sep 2025 · Cambridge, MA
  2. Reunion Neuroscience, Inc.$120MAnnounced9 Sep 2025 · Morristown, NJ
  3. Aktis Oncology, Inc.$175MFiled before 20252 Oct 2024 · Boston, MA
  4. Firefly Bio, Inc.$40MFiled before 202526 Mar 2024 · South San Francisco, CA

All 68 raises

Other unannounced rounds

  1. DVx Atomic Co.$18.5MUnannounced · 1 day16 Sep 2026 · Boston, MA
  2. Aperio Systems, Inc.$1.6MUnannounced · 1 day16 Sep 2026 · Boston, MA
  3. Twin Health, Inc.$59MUnannounced · 1 day16 Sep 2026 · Menlo Park, CA
  4. Scoring Factory AI Inc.$500KUnannounced · 2 days15 Sep 2026 · New York, NY
  5. Royal & Pelham, Inc.$5.4MUnannounced · 2 days15 Sep 2026 · New Orleans, LA
  6. SPECTRA Holdings US, Ltd.$2.5MUnannounced · 2 days15 Sep 2026 · Sandy Springs, GA

All unannounced rounds

Seen it announced?

Send the link and the check will look at it.